Sign In
Buy HLXB
Helix Acquisition . Ii Class A Ordinary Shares Stock Insider Power
Based on the 89 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 51.04M and sold 921.63K HLXB shares in the last 89 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
100.00 |
| ● Buy | 51.04M shares |
| ● Sell | 921.63K shares |
|
96% Buy Activity
Strong Negative Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Oct 10, 2025 Buy |
Bridgebio Pharma Llc 10 Percent Owner |
784 720 Value: $7.77M |
||
|
Oct 02, 2025 Buy |
Wallace Eli M. Chief Executive Officer |
1 614 400 Value: $20.1M |
||
|
Oct 02, 2025 Buy |
Wallace Eli M. Chief Executive Officer |
1 614 400 Value: $20.1M |
||
|
Aug 26, 2025 Buy |
Bauer Jake Director |
138 193 Value: $1.33M |
||
|
Aug 26, 2025 Buy |
Beltran Pedro Chief Scientific Officer |
357 177 Value: $3.43M |
||
|
Aug 26, 2025 Buy |
Ben Yong Chief Med & Dev Officer |
357 177 Value: $3.43M |
||
|
Aug 26, 2025 Buy |
Wallace Eli M. Chief Executive Officer |
499 731 Value: $4.79M |
||
|
Aug 26, 2025 Buy |
Mehra Uneek Chief Financial Officer |
633 570 Value: $6.08M |
||
|
Aug 26, 2025 Buy |
Mehra Uneek Chief Financial Officer |
633 570 Value: $6.08M |
||
|
Aug 26, 2025 Buy |
Wallace Eli M. Chief Executive Officer |
499 731 Value: $4.79M |
||
|
Aug 26, 2025 Buy |
Ben Yong Chief Med & Dev Officer |
357 177 Value: $3.43M |
||
|
Aug 26, 2025 Buy |
Beltran Pedro Chief Scientific Officer |
357 177 Value: $3.43M |
||
|
Aug 26, 2025 Buy |
Bauer Jake Director |
138 193 Value: $1.33M |
||
|
Aug 26, 2025 Buy |
Mccormick Frank Director |
91 076 Value: $873.4K |
||
|
Aug 26, 2025 Buy |
Tipirneni Praveen P. Director |
52 269 Value: $501.3K |
||
|
Aug 26, 2025 Buy |
Mccormick Frank Director |
91 076 Value: $873.4K |
||
|
Aug 26, 2025 Buy |
Tipirneni Praveen P. Director |
52 269 Value: $501.3K |
||
|
Aug 11, 2025 Buy |
Kumar Neil Insider |
0 Value: $0 |
||
|
Aug 11, 2025 Buy |
Ben Yong Chief Med & Dev Officer |
443 298 Value: $1.85M |
||
|
Aug 11, 2025 Buy |
Ben Yong Chief Med & Dev Officer |
26 551 Value: $209.2K |
||
|
Aug 11, 2025 Buy |
Wallace Eli M. Chief Executive Officer |
620 618 Value: $2.59M |
||
|
Aug 11, 2025 Buy |
Wallace Eli M. Chief Executive Officer |
37 172 Value: $292.9K |
||
|
Aug 11, 2025 Buy |
Mehra Uneek Insider |
0 Value: $0 |
||
|
Aug 11, 2025 Buy |
Beltran Pedro Chief Scientific Officer |
443 298 Value: $1.85M |
||
|
Aug 11, 2025 Buy |
Beltran Pedro Chief Scientific Officer |
26 551 Value: $209.2K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
